Victor Chumpitaz-Cerrate
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Victor Chumpitaz-Cerrate has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
- Lesly Chávez-Rimache
Instituto de Evaluación de Tecnologías en Salud e Investigación - IETSI, EsSalud, Lima, Peru
13 shared publications - César Franco-Quino
Research Group in Basic Stomatological Sciences (ICBEST), Universidad Nacional Mayor de San Marcos, Lima, Peru. Pharmacology Laboratory, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru
9 shared publications - Oscar Herrera-Calderon
Department of Pharmacology, Bromatology and Toxicology, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos, Lima 15001, Peru
9 shared publications Lesly Chávez-Rimache
Univ Nacl Mayor San Marcos, Invest Ciencias Bas Estomatol ICBEST Grp, Lima, Peru
6 shared publications- Johnny Aldo Tinco-Jayo
Department of Human Medicine, Faculty of Health Sciences, Universidad Nacional de San Cristobal de Huamanga, Portal Independencia 57, Ayacucho 05003, Peru
5 shared publications - Juan Pedro Rojas-Armas
Laboratory of Pharmacology, Faculty of Medicine, Universidad Nacional Mayor De San Marcos, Lima, Peru
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Universidad de Antioquia in Revista Facultad de Odontología
- Vol. 38 (1) , e360759
Assessment of Oral Mucosal Status in Populations Exposed to Different Concentrations of Arsenic in Drinking Water
Introduction: Arsenic (As) is a major public health concern due to its high toxicity and adverse effects on human health. The International Agency for Research on Cancer (IARC) has classified it as a human carcinogen, based on evidence linking its ingestion through drinking water to skin and lung cancer. The objective of this study was to assess oral mucosa status in populations exposed to different concentrations of As in a district of Lambayeque, Peru. Methods: an observational, descriptive, non-experimental, comparative study was conducted. The sample consisted of 164 patients. The Oral Assessment Guide was used as the evaluation instrument. Data were analyzed using inferential statistics (chi-square test). Results: no significant association was found between oral mucosa status and As concentration (p = 0.054). In the group exposed to high concentrations of As, 3.7 % showed alterations in oral cavity structures and 9.8 % presented severe alterations. Conclusion: although no statistically significant association was found, the results show a trend toward statistical significance (p = 0.054), suggesting that As exposure may negatively affect oral mucosa health in populations exposed to high concentrations.
- 1 January 2026
- Published by Universidad de Antioquia in Revista Facultad de Odontología
- Vol. 38 (1) , e360759
Open AccessAssessment of Oral Mucosal Status in Populations Exposed to Different Concentrations of Arsenic in Drinking Water
Introduction: Arsenic (As) is a major public health concern due to its high toxicity and adverse effects on human health. The International Agency for Research on Cancer (IARC) has classified it as a human carcinogen, based on evidence linking its ingestion through drinking water to skin and lung cancer. The objective of this study was to assess oral mucosa status in populations exposed to different concentrations of As in a district of Lambayeque, Peru. Methods: an observational, descriptive, non-experimental, comparative study was conducted. The sample consisted of 164 patients. The Oral Assessment Guide was used as the evaluation instrument. Data were analyzed using inferential statistics (chi-square test). Results: no significant association was found between oral mucosa status and As concentration (p = 0.054). In the group exposed to high concentrations of As, 3.7 % showed alterations in oral cavity structures and 9.8 % presented severe alterations. Conclusion: although no statistically significant association was found, the results show a trend toward statistical significance (p = 0.054), suggesting that As exposure may negatively affect oral mucosa health in populations exposed to high concentrations.
- 1 August 2025
- Published by Wiley in Oral Surgery
- Vol. 19 (1) , 68-77
Role of Corticosteroids as Adjunctive Therapy in Patients With Odontogenic Cervicofacial Infections: Systematic Review
Objective: The main aim is to evaluate the efficacy and safety of corticosteroid administration as adjuvant therapy in patients with odontogenic cervicofacial infections. Methods: We searched five databases, grey literature and manually reviewed bibliographic references for observational studies. Outcomes included hospital length of stay, intensive care unit admission, reoperation and other postoperative complications. The risk of bias was assessed using the Newcastle‐Ottawa Scale. Meta‐analyses were not performed due to the heterogeneity of the results. Results: We included four observational studies. Dexamethasone use reduced the odds of reoperation (odds ratio (OR): 0.9; 95% CI: 0.8–0.98). Additionally, higher doses of dexamethasone were associated with a shorter hospital stay (β: −0.2; 95% CI: −0.3 to −0.07). However, another study reported a longer hospital stay among patients who received corticosteroids than those who did not; p < 0.001. Furthermore, corticosteroid use was associated with lower odds of intensive care unit admission (OR: 0.51; 95% CI: 0.09–2.72); p > 0.05. The only reported adverse event was prolonged hyperglycemia (0.8%). Conclusions: The adjuvant use of corticosteroids in managing patients with odontogenic cervicofacial infections has potential beneficial effects and appears safe. However, the evidence remains unclear, and further studies are needed to evaluate potential benefits and harms.
- 1 August 2025
- Published by Wiley in Oral Surgery
- Vol. 19 (1) , 68-77
Role of Corticosteroids as Adjunctive Therapy in Patients With Odontogenic Cervicofacial Infections: Systematic Review
Objective: The main aim is to evaluate the efficacy and safety of corticosteroid administration as adjuvant therapy in patients with odontogenic cervicofacial infections. Methods: We searched five databases, grey literature and manually reviewed bibliographic references for observational studies. Outcomes included hospital length of stay, intensive care unit admission, reoperation and other postoperative complications. The risk of bias was assessed using the Newcastle‐Ottawa Scale. Meta‐analyses were not performed due to the heterogeneity of the results. Results: We included four observational studies. Dexamethasone use reduced the odds of reoperation (odds ratio (OR): 0.9; 95% CI: 0.8–0.98). Additionally, higher doses of dexamethasone were associated with a shorter hospital stay (β: −0.2; 95% CI: −0.3 to −0.07). However, another study reported a longer hospital stay among patients who received corticosteroids than those who did not; p < 0.001. Furthermore, corticosteroid use was associated with lower odds of intensive care unit admission (OR: 0.51; 95% CI: 0.09–2.72); p > 0.05. The only reported adverse event was prolonged hyperglycemia (0.8%). Conclusions: The adjuvant use of corticosteroids in managing patients with odontogenic cervicofacial infections has potential beneficial effects and appears safe. However, the evidence remains unclear, and further studies are needed to evaluate potential benefits and harms.
- 1 January 2024
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 31 (1) , GC8-GC16
Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets
- 1 January 2024
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 31 (1) , GC8-GC16
Therapeutic Equivalence of Multisource Drugs Assessed by In Vitro Dissolution Studies: Amoxicillin/Clavulanic Acid Tablets
- Open Access
- 30 December 2023
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Odontología Sanmarquina
- Vol. 26 (4) , e25753
Efecto del tratamiento con ácido zoledrónico e hidroxocobalamina sobre la microarquitectura ósea en ratones con periodontitis y osteoporosis inducida: Estudio preclínico
Objective. Evaluate the effect of zoledronic acid and hydroxocobalamin treatment on alveolar bone microarchitecture in mice with induced periodontitis and osteoporosis. Methods. Experimental design in preclinical phase. Sixteen female mice were included in which osteoporosis was induced by total ovariectomy and periodontitis was also induced by inflammation by 5/0 black silk ligation of the maxillary second molar, all protocols were performed under general anesthesia. The mice were distributed into 4 groups: control, treatment with zoledronic acid, treatment with hydroxocobalamin and combined treatment. At 16 weeks, euthanasia was performed, dissection was performed for evaluation by microtomography; determining bone mineral density (BMD), bone volume (BV/TV), trabecular thickness (Tb.Th), number of trabeculae (Tb.N), trabecular separation (Tb.Sp); descriptive and bivariate analysis was performed using 1-way ANOVA with a 95% confidence level. Results. The group that received combined treatment of zoledronic acid and hydroxocobalamin presented higher bone mineral density (BMD), higher bone volume (BV/TV) and lower trabecular separation (Tb.Sp) compared to the control group (p<0.05). Conclusions. Combined treatment with zoledronic acid and hydroxocobalamin improves bone microarchitectural features in mice with induced osteoporosis and periodontitis.
- 30 December 2023
- Published by Universidad Nacional Mayor de San Marcos, Vicerectorado de Investigacion in Odontología Sanmarquina
- Vol. 26 (4) , e25753
Open AccessEfecto del tratamiento con ácido zoledrónico e hidroxocobalamina sobre la microarquitectura ósea en ratones con periodontitis y osteoporosis inducida: Estudio preclínico
Objective. Evaluate the effect of zoledronic acid and hydroxocobalamin treatment on alveolar bone microarchitecture in mice with induced periodontitis and osteoporosis. Methods. Experimental design in preclinical phase. Sixteen female mice were included in which osteoporosis was induced by total ovariectomy and periodontitis was also induced by inflammation by 5/0 black silk ligation of the maxillary second molar, all protocols were performed under general anesthesia. The mice were distributed into 4 groups: control, treatment with zoledronic acid, treatment with hydroxocobalamin and combined treatment. At 16 weeks, euthanasia was performed, dissection was performed for evaluation by microtomography; determining bone mineral density (BMD), bone volume (BV/TV), trabecular thickness (Tb.Th), number of trabeculae (Tb.N), trabecular separation (Tb.Sp); descriptive and bivariate analysis was performed using 1-way ANOVA with a 95% confidence level. Results. The group that received combined treatment of zoledronic acid and hydroxocobalamin presented higher bone mineral density (BMD), higher bone volume (BV/TV) and lower trabecular separation (Tb.Sp) compared to the control group (p<0.05). Conclusions. Combined treatment with zoledronic acid and hydroxocobalamin improves bone microarchitectural features in mice with induced osteoporosis and periodontitis.
- Open Access
- 11 December 2023
- Published by Universidad de Costa Rica in Odovtos - International Journal of Dental Sciences
- Vol. 26 (1) , 14-20
Radical Surgical Approach to Chronic Suppurative Osteomyelitis: Case Report
Diabetes mellitus is a systemic condition potentially related to an increased risk of progression of various infections such as chronic osteomyelitis by accelerating the inflammatory process with bone tissue necrosis and suppuration. Therefore, if there is no proper management of these infections, they can be life-threatening as they spread to deeper spaces in the head and neck. We describe the case of a 52-year-old male patient with a history of diabetes mellitus and grade III osteoarthritis who was diagnosed with chronic suppurative osteomyelitis of the mandible. He underwent a multidisciplinary surgical intervention in which he underwent a hemimandibulectomy with immediate mandibular reconstruction. The present case highlights the importance of early and radical treatment of patients with chronic suppurative osteomyelitis of the mandible and systemic comorbidities. In addition, this case presents a review of diabetes mellitus and the risk of developing odontogenic infections and complications when invading deeper spaces in the head and neck. Therefore, in this population, careful planning is required for early surgical and pharmacological treatment.
- 11 December 2023
- Published by Universidad de Costa Rica in Odovtos - International Journal of Dental Sciences
- Vol. 26 (1) , 14-20
Open AccessRadical Surgical Approach to Chronic Suppurative Osteomyelitis: Case Report
Diabetes mellitus is a systemic condition potentially related to an increased risk of progression of various infections such as chronic osteomyelitis by accelerating the inflammatory process with bone tissue necrosis and suppuration. Therefore, if there is no proper management of these infections, they can be life-threatening as they spread to deeper spaces in the head and neck. We describe the case of a 52-year-old male patient with a history of diabetes mellitus and grade III osteoarthritis who was diagnosed with chronic suppurative osteomyelitis of the mandible. He underwent a multidisciplinary surgical intervention in which he underwent a hemimandibulectomy with immediate mandibular reconstruction. The present case highlights the importance of early and radical treatment of patients with chronic suppurative osteomyelitis of the mandible and systemic comorbidities. In addition, this case presents a review of diabetes mellitus and the risk of developing odontogenic infections and complications when invading deeper spaces in the head and neck. Therefore, in this population, careful planning is required for early surgical and pharmacological treatment.
- Open Access
- 3 April 2023
- Published by Maad Rayan Publishing Company in Journal of Dental Research, Dental Clinics, Dental Prospects
- Vol. 17 (1) , 47-53
Comparison of the anesthetic effect of alkalized lidocaine versus non-alkalized lidocaine administered at a slow rate in mandibular primary molars
Background. There are several invasive dental procedures that require local anesthetics. However, its infiltration is usually associated with anxiety and fear, increasing the perception of pain in pediatric patients. For this reason, it is important to evaluate different strategies for its application. We compared the anesthetic effect of the administration of 2% lidocaine with epinephrine 1:80000 non-alkalized at slow speed and alkalized at fast speed to block the inferior alveolar nerve in deciduous molars. Methods. A crossover clinical trial was carried out whose sample consisted of 38 patients between 6-10 years who required bilateral pulp treatment in their first mandibular primary molars. At the first appointment, they received 2% lidocaine with 1:80000 alkalinized epinephrine administered at a fast rate, and at the second appointment, 2% lidocaine with 1:80000 non-alkalized epinephrine administered at a low speed. We evaluated the onset of action, duration of the anesthetic effect, and intensity of pain during its infiltration. Results. We found that non-alkalized lidocaine at slow speed had a shorter onset time of action (57.21±22.21 seconds) and longer duration of effect (170.82±43.75 minutes) compared to administration of alkalinized lidocaine at fast speed (74.03±22.09 seconds, 148.24±36.24 minutes, respectively). There was no difference in the level of pain intensity. Conclusion. In this study, the slow administration of the non-alkalized local anesthetic showed a shorter onset time of action and a longer duration of the anesthetic effect in comparison with the alkalized local anesthetic administered at a rapid rate in the blockade of the inferior alveolar nerve in deciduous molars.
- 3 April 2023
- Published by Maad Rayan Publishing Company in Journal of Dental Research, Dental Clinics, Dental Prospects
- Vol. 17 (1) , 47-53
Open AccessComparison of the anesthetic effect of alkalized lidocaine versus non-alkalized lidocaine administered at a slow rate in mandibular primary molars
Background. There are several invasive dental procedures that require local anesthetics. However, its infiltration is usually associated with anxiety and fear, increasing the perception of pain in pediatric patients. For this reason, it is important to evaluate different strategies for its application. We compared the anesthetic effect of the administration of 2% lidocaine with epinephrine 1:80000 non-alkalized at slow speed and alkalized at fast speed to block the inferior alveolar nerve in deciduous molars. Methods. A crossover clinical trial was carried out whose sample consisted of 38 patients between 6-10 years who required bilateral pulp treatment in their first mandibular primary molars. At the first appointment, they received 2% lidocaine with 1:80000 alkalinized epinephrine administered at a fast rate, and at the second appointment, 2% lidocaine with 1:80000 non-alkalized epinephrine administered at a low speed. We evaluated the onset of action, duration of the anesthetic effect, and intensity of pain during its infiltration. Results. We found that non-alkalized lidocaine at slow speed had a shorter onset time of action (57.21±22.21 seconds) and longer duration of effect (170.82±43.75 minutes) compared to administration of alkalinized lidocaine at fast speed (74.03±22.09 seconds, 148.24±36.24 minutes, respectively). There was no difference in the level of pain intensity. Conclusion. In this study, the slow administration of the non-alkalized local anesthetic showed a shorter onset time of action and a longer duration of the anesthetic effect in comparison with the alkalized local anesthetic administered at a rapid rate in the blockade of the inferior alveolar nerve in deciduous molars.
- Open Access
- 31 January 2023
- Published by Universidad Latina de Costa Rica in Odontología Vital
- Vol. 1 (38) , 34-44
Fluorosis dental en adolescentes de Instituciones Educativas de Lima, Perú.
Introducción: La fluorosis dental es una patología endémica causada por la ingestión excesiva de fluoruros que pueden producir una alteración durante el desarrollo del esmalte, y es considerado un importante problema de salud pública porque afecta la salud bucal y sistémica de la población. Objetivo: Este estudio tuvo como idea principal determinar la frecuencia y los niveles de fluorosis dental en escolares de 12 a 15 años pertenecientes a dos instituciones educativas de Lima - Perú. Método: Se realizó un estudio descriptivo de tipo transversal, la muestra estuvo conformada por 252 estudiantes, entre 12 y 15 años de dos centros educativos de Lima. El muestreo fue por selección sistemática de elementos muestrales. La fluorosis dental se evalúo mediante el Índice de Dean. Para determinar la frecuencia y los niveles de fluorosis dental, se realizó un examen clínico bucal y se desarrolló un cuestionario validado previamente. Resultados: La frecuencia de fluorosis dental fue de 44,8% (n=113) afectando más a los varones en un 27,39% (n=69) y a los adolescentes de 13 años (15,1%). En relación con los niveles de fluorosis, predominó el tipo “muy leve” (34,9%). También se encontró una asociación entre la presencia y el nivel de fluorosis con el número de aplicaciones de flúor (p<0,05). Además, se dijo que el índice comunitario de fluorosis de Dean fue de 0,43. Conclusiones: En la población escolar evaluada, la frecuencia de fluorosis fue de 44,8% y el nivel predominante de fluorosis fue muy leve. Además, el índice comunitario fue de 0,43, el cual mostró un nivel límite de importancia para la salud pública. Por lo que se puede considerar que el número de aplicaciones tópicas de flúor recibido por la población sin una planificación adecuada se podría convertir en un factor de riesgo para causar fluorosis dental.
- 31 January 2023
- Published by Universidad Latina de Costa Rica in Odontología Vital
- Vol. 1 (38) , 34-44
Open AccessFluorosis dental en adolescentes de Instituciones Educativas de Lima, Perú.
Introducción: La fluorosis dental es una patología endémica causada por la ingestión excesiva de fluoruros que pueden producir una alteración durante el desarrollo del esmalte, y es considerado un importante problema de salud pública porque afecta la salud bucal y sistémica de la población. Objetivo: Este estudio tuvo como idea principal determinar la frecuencia y los niveles de fluorosis dental en escolares de 12 a 15 años pertenecientes a dos instituciones educativas de Lima - Perú. Método: Se realizó un estudio descriptivo de tipo transversal, la muestra estuvo conformada por 252 estudiantes, entre 12 y 15 años de dos centros educativos de Lima. El muestreo fue por selección sistemática de elementos muestrales. La fluorosis dental se evalúo mediante el Índice de Dean. Para determinar la frecuencia y los niveles de fluorosis dental, se realizó un examen clínico bucal y se desarrolló un cuestionario validado previamente. Resultados: La frecuencia de fluorosis dental fue de 44,8% (n=113) afectando más a los varones en un 27,39% (n=69) y a los adolescentes de 13 años (15,1%). En relación con los niveles de fluorosis, predominó el tipo “muy leve” (34,9%). También se encontró una asociación entre la presencia y el nivel de fluorosis con el número de aplicaciones de flúor (p<0,05). Además, se dijo que el índice comunitario de fluorosis de Dean fue de 0,43. Conclusiones: En la población escolar evaluada, la frecuencia de fluorosis fue de 44,8% y el nivel predominante de fluorosis fue muy leve. Además, el índice comunitario fue de 0,43, el cual mostró un nivel límite de importancia para la salud pública. Por lo que se puede considerar que el número de aplicaciones tópicas de flúor recibido por la población sin una planificación adecuada se podría convertir en un factor de riesgo para causar fluorosis dental.
- Open Access
- 31 October 2022
- Published by Medknow in Journal of International Society of Preventive and Community Dentistry
- Vol. 12 (5) , 488-499
Evaluation of Current Evidence on the Use of Oral Antiseptics Against SARS-CoV-2
Aims and Objectives: The detection of SARS-COV-2 in the oral cavity has generated endless claims about the efficacy of using oral mouthwashes to reduce viral load. This review aims to assess the current evidence on the use of oral antiseptics against SARS-CoV-2 and to assess the certainty of the evidence according to the GRADE system. The question this study focussed on was what is the efficacy of oral antiseptics against SARS-CoV-2? Materials and Methods: A bibliographic search was performed in Medline databases through PubMed, Science Direct, and Google Scholar (until February 2022), using search terms related to COVID-19 and oral antiseptics. Two independent researchers extracted the information from the articles included in an excel form. The identification and selection of the studies was carried out from August 2021 to February 2022. Results: It was found that oral antiseptics can have a potential beneficial effect on COVID-19, mainly in reducing viral load. However, these potential benefits are mainly based on in-vitro studies or clinical studies with various methodological limitations. At present, the certainty of the evidence is very low due to inconsistency (heterogeneity), moderate-to-high risk of bias, and imprecision of the results. Conclusion: The certainty of the current evidence on the efficacy of oral antiseptics against SARS-CoV-2 is very low, mainly due to the methodological limitations of the studies. Therefore, for evidence-based decision-making about this intervention, clinical studies with greater methodological rigor are required. Oral antiseptics could present potential benefits in patients with COVID-19 mainly by reducing viral load. However, a careful and conscious evaluation of the evidence is required for decision-making in clinical practice.
- 31 October 2022
- Published by Medknow in Journal of International Society of Preventive and Community Dentistry
- Vol. 12 (5) , 488-499
Open AccessEvaluation of Current Evidence on the Use of Oral Antiseptics Against SARS-CoV-2
Aims and Objectives: The detection of SARS-COV-2 in the oral cavity has generated endless claims about the efficacy of using oral mouthwashes to reduce viral load. This review aims to assess the current evidence on the use of oral antiseptics against SARS-CoV-2 and to assess the certainty of the evidence according to the GRADE system. The question this study focussed on was what is the efficacy of oral antiseptics against SARS-CoV-2? Materials and Methods: A bibliographic search was performed in Medline databases through PubMed, Science Direct, and Google Scholar (until February 2022), using search terms related to COVID-19 and oral antiseptics. Two independent researchers extracted the information from the articles included in an excel form. The identification and selection of the studies was carried out from August 2021 to February 2022. Results: It was found that oral antiseptics can have a potential beneficial effect on COVID-19, mainly in reducing viral load. However, these potential benefits are mainly based on in-vitro studies or clinical studies with various methodological limitations. At present, the certainty of the evidence is very low due to inconsistency (heterogeneity), moderate-to-high risk of bias, and imprecision of the results. Conclusion: The certainty of the current evidence on the efficacy of oral antiseptics against SARS-CoV-2 is very low, mainly due to the methodological limitations of the studies. Therefore, for evidence-based decision-making about this intervention, clinical studies with greater methodological rigor are required. Oral antiseptics could present potential benefits in patients with COVID-19 mainly by reducing viral load. However, a careful and conscious evaluation of the evidence is required for decision-making in clinical practice.
- 1 April 2022
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 123 (2) , 147-148
Need for randomized clinical Trials on the management of pain, inflammation and trismus in surgery of impacted third molars
- 1 April 2022
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 123 (2) , 147-148
Need for randomized clinical Trials on the management of pain, inflammation and trismus in surgery of impacted third molars
- 1 January 2022
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 29 (1)
Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru
- 1 January 2022
- Published by Dissolution Technologies in Dissolution Technologies
- Vol. 29 (1)
Therapeutic Equivalence Evaluated Through In Vitro Studies of Multi-Source Drugs: A Moxifloxacin Case Study in Lima, Peru